Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
SNAP-8
Batch #
N/A
Formula
C41H70N16O16S
Mol Wt
1075.2 g/mol
CAS
868844-74-0
Latest
ISO 17025
8× Testing
99.7%
Purity
VariantSNAP-8
COA ##13130
Labeled10mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.7%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - SNAP-8
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Snap-8 and Argireline for the treatment of facial wrinkles: a clinical study
02
Acetyl octapeptide-3 (SNAP-8): in vitro inhibition of SNARE complex formation
03
Botulinum neurotoxin and peptide mimetics: structure, function and cosmetic applications
04
Efficacy of anti-wrinkle peptides in topical cosmetic applications
05
Inhibitory peptides targeting the SNARE complex as cosmetic anti-aging agents
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
